These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36864821)

  • 21. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.
    Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?].
    Bourgault-Villada I
    Ann Dermatol Venereol; 1998 Dec; 125(12):879-80. PubMed ID: 9922858
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
    Koyanagi S; Koizumi J; Nakase K; Hayashi N; Horiuchi Y; Watanabe K; Asai T; Yamazaki A; Nakazaki E; Nakaminami H
    J Dermatol; 2023 Jun; 50(6):793-799. PubMed ID: 36880295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased prevalence of doxycycline low-susceptible Cutibacterium acnes isolated from acne patients in Japan caused by antimicrobial use and diversification of tetracycline resistance factors.
    Aoki S; Nakase K; Hayashi N; Nakaminami H; Noguchi N
    J Dermatol; 2021 Sep; 48(9):1365-1371. PubMed ID: 33998707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.
    Sheffer-Levi S; Rimon A; Lerer V; Shlomov T; Coppenhagen-Glazer S; Rakov C; Zeiter T; Nir-Paz R; Hazan R; Molho-Pessach V
    Acta Derm Venereol; 2020 Oct; 100(17):adv00295. PubMed ID: 33021324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial Activity of
    Joo JH; Han MH; Kim JI; Kim JE; Jung KH; Oh HS; Chung YS; An HJ; Lee JD; Moon GS; Lee HY
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of bacteriophage φPaP11-13 attenuates rat
    Liu Y; Zhen N; Liao D; Niu J; Liu R; Li Z; Lei Z; Yang Z
    Microbiol Spectr; 2024 Feb; 12(2):e0283823. PubMed ID: 38197658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taxonomy and phylogeny of Cutibacterium (formerly Propionibacterium) acnes in inflammatory skin diseases.
    Corvec S; Dagnelie MA; Khammari A; Dréno B
    Ann Dermatol Venereol; 2019 Jan; 146(1):26-30. PubMed ID: 30558958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
    Özel Kaya N; Usta İ; Demirçay ZÖ; Ülger Toprak N
    Mikrobiyol Bul; 2021 Oct; 55(4):465-479. PubMed ID: 34666649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propionibacterium acnes is developing gradual increase in resistance to oral tetracyclines.
    Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
    J Med Microbiol; 2017 Jan; 66(1):8-12. PubMed ID: 28218057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M
    Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INDIVIDUAL ARTICLE: Antibiotic Stewardship in Acne: 2023 Update.
    Issa NT; Kircik LH
    J Drugs Dermatol; 2024 Feb; 23(2):SF37896s4-SF378969s10. PubMed ID: 38306149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An overview of sarecycline for the treatment of moderate-to-severe acne vulgaris.
    Valente Duarte de Sousa IC
    Expert Opin Pharmacother; 2021 Feb; 22(2):145-154. PubMed ID: 32924666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
    Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
    J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial toner exhibits bactericidal effect against Cutibacterium acnes via keratin and sebum plug penetration.
    Hamada S; Nakamura Y; Gomi M
    J Microorg Control; 2024; 29(2):63-73. PubMed ID: 38880618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: A Japanese multicenter study.
    Nakase K; Aoki S; Sei S; Fukumoto S; Horiuchi Y; Yasuda T; Tanioka M; Sugai J; Huh WW; Kakuta M; Nomoto M; Shimada T; Watanabe M; Kobayashi M; Murakami S; Takeo C; Tsubouchi R; Hayashi N; Noguchi N
    J Dermatol; 2020 Aug; 47(8):863-869. PubMed ID: 32424832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.